Key Proteo and Eton Pharmaceutical Sign Memorandum of Understanding

Key Proteo is excited to announce that it has entered into a Memorandum of Understanding (MOU) with Eton Pharmaceutical to explore potential avenues of collaboration. This partnership reflects a shared commitment to advancing healthcare solutions, particularly in the area of newborn screening, by leveraging the complementary strengths of both parties. Together, the two organizations will explore innovative approaches in diagnostics and pharmaceutical development, aiming to deliver greater value to patients and healthcare providers alike.

We look forward to the possibilities this collaboration may bring.